US 10100013
Crystalline freebase forms of a biphenyl compound
granted A61KA61K31/4545A61K45/06
Quick answer
US patent 10100013 (Crystalline freebase forms of a biphenyl compound) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623